Surefire Medical (Westminster, CO) a development-stage medical device company focused on interventional radiology embolic agent delivery, closed a $6.1M Series A financing. Participants include Partisan Management Group and High Country Venture.

CardioKinetix (Redwood City, CA) a clinical-stage medical device company focused on transcatheter implants for congestive heart failure, closed a $44M Series E financing. Participants include SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners, J.P. Morgan Partners, H&Q Healthcare Investors and H&Q Life Sciences Investors.

Access Scientific (San Diego, CA) a commercial-stage medical device company focused on an over-wire vascular micro-access wand, closed a $10M Series C financing. Participants were not identified.
The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact arubenstein@rnaventures.com [...]

Mirador Biomedical (Seattle, WA) a development-stage medical device company focused on single use pressure transducers for use with central venous catheters, closed a $1.5M Series B financing. Participants include WRF Capital and Summit Capital.

Vascular Pathways (Los Altos, CA) a clinical-stage medical device company focused on rapid peripheral intravenous access, closed a $14M Series B financing. Participants include CHL Medical Partners, Ascension Health Ventures, MVM Life Science Partners and Arcus Ventures.

Great Lakes Pharmaceuticals (Cleveland, OH) a clinical-stage drug:device company focused on catheter-related bloodstream infection, closed a $3.1M Series B financing. Participants include Charter Life Sciences, Early Stage Partners, Ohio Tech Angels and North Coast Angel Fund.

Endosense (Switzerland) a commercial-stage medical device company focused on catheter ablation for the treatment of cardiac arrhythmias, closed a $36M Series B financing. Participants include Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital and Initiative Capital Romandie.

Catheter Connections ( Park City, UT) an early-stage focused on accessory products for the prevention of infection in the vascular catheter access device market, closed a $1.3M Series A financing. Participants include vSpring Capital and Kickstart Seed Fund.

iScience Interventional (Menlo Park, CA) a commercial-stage microcatheter device for the treatment of ocular diseases open-angle glaucoma and clinical-stage development focused on wet-AMD, closed a $20.5M Series F financing. Participants include Affinity Capital Management, Johnson & Johnson Development Corp., L Capital Partners, Clarian Health Ventures, Prism VentureWorks, Three Arch Ventures, DeNovo Ventures and Asset Management [...]

Ardian (Palo Alto, CA) a clinical-stage medical device company focused on catheter-based treatment for hypertension, chronic kidney disease and heart failure, closed a $47M Series C financing. Participants include Medtronic, Emergent Medical Partners, Advanced Technology Ventures, Morgenthaler Ventures and Split Rock Partners.

Concentric Medical (Mountain View, CA) a commercial-stage medical device company commercializing products for the restoration of blood flow in patients who are experiencing an ischemic stroke, closed a $15M Series D financing. Participants include New Enterprise Associates.

Flexicath (Israel) an early-stage developer of intravenous catheterization devices closed a $0.6M Series B financing. Participants include the Zitelman Group.

VasoNova (Sunnyvale, CA) developer of a self-guided peripherally inserted central catheters, closed a $10M Series B financing. Participants include Arboretum Ventures, Aphelion Capital, Coronis Medical Ventures and Research Corporation Technologies, Coronis Medical Ventures and Life Science Angels.